SSG
BLFS icon

Summit Securities Group’s BioLife Solutions BLFS Stock Holding History

Summit Securities Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
+6,000
New +$140K 0.02% 299
2025
Q3 		– Sell
-4,978
Closed -$107K – 1045
2025
Q2 		$107K Buy
+4,978
New +$112K 0.02% 351

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Summit Securities Group's BLFS Position: Q2 2026 in Review

Summit Securities Group opened a new position in BioLife Solutions (BLFS) in Q2 2026: 6,000 shares worth $169K. The stake represents 0.02% of the portfolio and ranks #299 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in BLFS as recently as Q2 2025.

Summit Securities Group first reported a position in BLFS in Q2 2025 and has held it in 2 quarters since. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Summit Securities Group held 6,000 shares of BioLife Solutions worth $169K as of Q2 2026.
  • BioLife Solutions was a new Summit Securities Group position in Q2 2026.
  • BioLife Solutions made up 0.02% of Summit Securities Group's portfolio in Q2 2026, its #299 holding.
  • Summit Securities Group first reported a position in BioLife Solutions in Q2 2025 and has held it in 2 quarters since.
  • 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.